Ambassador Advisors, LLC Horizon Therapeutics Public LTD CO Transaction History

Ambassador Advisors, LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 18, 2022	BUY	$58.92 - $84.67 $226,193 - $325,048	3,839 Added 15.62%	28,414 $1.76 Million
Q2 2022 Aug 12, 2022	BUY	$79.4 - $116.36 $15,244 - $22,341	192 Added 0.79%	24,575 $1.96 Million
Q1 2022 May 16, 2022	BUY	$86.42 - $109.81 $107,420 - $136,493	1,243 Added 5.37%	24,383 $2.57 Million
Q4 2021 Feb 14, 2022	SELL	$98.56 - $119.91 $855,697 - $1.04 Million	-8,682 Reduced 27.28%	23,140 $2.49 Million
Q3 2021 Nov 16, 2021	BUY	$91.91 - $110.37 $5,238 - $6,291	57 Added 0.18%	31,822 $3.49 Million
Q2 2021 Aug 16, 2021	BUY	$86.24 - $95.92 $106,592 - $118,557	1,236 Added 4.05%	31,765 $2.97 Million
Q1 2021 May 13, 2021	SELL	$71.83 - $95.48 $8,835 - $11,744	-123 Reduced 0.4%	30,529 $2.81 Million
Q4 2020 Feb 17, 2021	SELL	$67.0 - $84.39 $77,921 - $98,145	-1,163 Reduced 3.66%	30,652 $2.24 Million
Q3 2020 Nov 13, 2020	BUY	$55.23 - $79.93 $1.76 Million - $2.54 Million	31,815 New	31,815 $2.47 Million

2.07M

20K

Ticker HZNP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 230,384,000
Description
Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...

Get notified when there are updates to the investment portfolio of Ambassador Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Ambassador Advisors, LLC with notifications on news.